Tibolone inhibits bone resorption without secondary positive effects on cartilage degradation
2008

Tibolone and Its Effects on Bone and Cartilage

Sample size: 91 publication 10 minutes Evidence: moderate

Author Information

Author(s): Karsdal MA, Byrjalsen I, Leeming DJ, Christiansen C

Primary Institution: Nordic Bioscience A/S

Hypothesis

Does Tibolone have dual actions on both bone and cartilage turnover similar to some SERMs and HRT?

Conclusion

Tibolone significantly decreases bone resorption without affecting cartilage degradation.

Supporting Evidence

  • Tibolone suppressed bone resorption by approximately 60%.
  • No effect was observed on cartilage degradation.
  • The study involved a total of 91 participants.

Takeaway

Tibolone helps bones stay strong but doesn't help cartilage, which is different from some other treatments.

Methodology

Secondary analysis of a 2-year double-blind, randomized, placebo-controlled study with urine samples collected at multiple time points.

Potential Biases

Potential bias due to the study being conducted by employees of Nordic Bioscience.

Limitations

The study relied on biochemical markers for cartilage degradation, which may not fully represent cartilage health across all joints.

Participant Demographics

Healthy postmenopausal women aged 52–75 years.

Statistical Information

P-Value

<0.001

Confidence Interval

95% confidence interval -17%;+70%

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/1471-2474-9-153

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication